Imatinib Unknown Status Phase 2 Trials for Chronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01221376Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)